MOTS-c is an unregulated research compound, FDA-ineligible for compounding, and prohibited by WADA under S4.4.1 (AMPK activators)
PlexusDx Compounded Semaglutide Injection is $189/mo month-to-month (or $149/mo on the 6-month plan), making long-term maintenance accessible without insurance
This makes the combo especially attractive for Indian fitness enthusiasts aiming for fat loss without sacrificing muscle mass
10.1016/j.diabres.2014.01.010 24 MonamiM.NreuB.ScatenaA.CresciB.AndreozziF.SestiG.et al (2017)
In laboratory settings, Dihexa has been studied for its relationship to cell signaling pathways, receptor interaction, synaptic architecture, and neurobiological communication systems in non-human experimental models
Results are presented visually by treatment cohort and T2DM status at 12 months in this study, but data points and sample sizes are not stated, preventing interpretation and comparison of outcomes with those from the current study [25]